From: Risk factors for the recurrence of relapsing polychondritis
Present study | |
---|---|
Total recurrence | |
Total number of patients with recurrence (number) | 25 |
Total number of recurrences (times) | 64 |
Mean number of recurrences (times/person) | 2.56 |
Person-years | 0.16 |
Major recurrence, n (%) | 11 (17.2) |
Minor recurrence, n (%) | 53 (82.8) |
Initial recurrence, n=25 | |
Median age at initial recurrence (years) | 51 (40–67) |
Median days to initial recurrence (days) | 202 (55–382) |
Major recurrence, n (%) | 6 (24.0) |
Minor recurrence, n (%) | 19 (76.0) |
Median PSL doses at initial recurrence (mg) | 10 (5–12.75) |
Symptoms at initial recurrence | |
Tracheobronchial involvement | 10 (40.0) |
Auricular involvement | 6 (24.0) |
Nasal involvement | 3 (12.0) |
Articular involvement | 3 (12.0) |
Eye involvement | 2 (8.0) |
Vestibulocochlear involvement | 2 (8.0) |
Encephalitis | 1 (4.0) |
Concordance of initial symptoms and symptoms at initial recurrence | 17 (68.0) |